Research finding could lead to new therapies for patients with gluten intolerance

April 1, 2014

Researchers at McMaster University have discovered a key molecule that could lead to new therapies for people with celiac disease, an often painful and currently untreatable autoimmune disorder.

Celiac disease is a sensitivity to dietary contained in cereals. In people who are genetically predisposed, gluten containing food will trigger an immune response that leads to destruction of the intestinal lining, abdominal pain, changes in bowel habits, malnutrition and many other symptoms that include anemia, and neurological problems.

People with this disease cannot eat food containing wheat, rye or barley, which is a main source of protein intake in the western diet.

Researchers in the Farncombe Family Digestive Health Research Institute at McMaster University have discovered that a molecule, elafin, which is present in the intestine of healthy individuals, is significantly decreased in patients with . The research was published in The American Journal of Gastroenterology.

When people with celiac disease eat food containing gluten , the digestive enzymes cannot digest it, and left over peptides from digestion induce inflammation. This inflammation is further amplified by an enzyme called tissue transglutaminase 2.

An intriguing finding of the research, say scientists, was that elafin, by interacting with the transglutaminase 2 enzyme, decreased the enzymatic reaction that increases the toxicity of peptides derived from gluten. In studies with mice, the researchers found that the administration of the elafin molecule protects the intestinal lining of the upper gut that is damaged by gluten.

Following a gluten-free diet is very difficult, because gluten is used not only in the food industry but in the cosmetic and pharmaceutical industries as a common, low cost filler.

"People who have to strictly avoid gluten for life often find this very difficult due to these hidden sources," said Elena Verdu, associate professor of Medicine in the Michael G. DeGroote School of Medicine. "There is a great need for a therapy that will protect patients with celiac disease from these accidental contaminations."

Verdu says the results raise the possibility of elafin administration or replacement as a new adjuvant therapy to the . "This would add flexibility to a restrictive lifelong diet, and increase patients' quality of life and potentially accelerate the healing of celiac lesions."

The research has implications beyond celiac disease.

Recently, has been reported in patients who do not have celiac disease (non-celiac gluten sensitivity).

Development of new therapies such as this one could help in the management of common gastrointestinal disorders such as irritable bowel syndrome that could be also triggered by wheat containing food.

Explore further: FDA defining what "gluten free" means on packages

Related Stories

FDA defining what "gluten free" means on packages

August 2, 2013
Consumers are going to know exactly what they're getting when they buy foods labeled "gluten free."

Quinoa may be safe grain for people with celiac disease

January 21, 2014
(HealthDay)—The grain quinoa seems safe for people with celiac disease, a new British study suggests.

Celiac disease linked to increased risk of coronary artery disease

March 29, 2014
People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual ...

Good diet helps people manage celiac disease

May 10, 2013
(HealthDay)—For people with celiac disease, an accurate diagnosis and proper diet are essential for good health, experts say.

Recommended for you

Four simple tests could help GPs spot pneumonia and reduce unnecessary antibiotics

November 23, 2017
Testing for fever, high pulse rate, crackly breath sounds, and low oxygen levels could be key to helping GPs distinguish pneumonia from less serious infections, according to a large study published in the European Respiratory ...

New approach to tracking how deadly 'superbugs' travel could slow their spread

November 22, 2017
Killer bacteria - ones that have out-evolved our best antibiotics—may not go away anytime soon. But a new approach to tracking their spread could eventually give us a fighting chance to keep their death toll down.

Research points to diagnostic test for top cause of liver transplant in kids

November 22, 2017
Biliary atresia is the most common cause of liver transplants for children in the United States. Now researchers report in Science Translational Medicine finding a strong biomarker candidate that could be used for earlier ...

Metabolites altered in chronic kidney disease

November 22, 2017
Chronic kidney disease (CKD) affects 1 in 7 people in the United States, according to the U.S. National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK). These individuals have a very high risk of cardiovascular ...

Rainfall can indicate that mosquito-borne epidemics will occur weeks later

November 22, 2017
A new study demonstrates that outbreaks of mosquito-borne viruses Zika and Chikungunya generally occur about three weeks after heavy rainfall.Researchers also found that Chikungunya will predominate over Zika when both circulate ...

Alcohol consumption and metabolic factors act together to increase the risk of severe liver disease

November 22, 2017
A new study provides insights into the interaction between alcohol consumption and metabolic factors in predicting severe liver disease in the general population. The findings, which are published in Hepatology, indicate ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

kitkellison
not rated yet Apr 01, 2014
While I'm always glad to see articles that show that there is interest by researchers in celiac disease, I want to point out that celiac disease and non-celiac gluten sensitivity (the word "intolerance" is really no longer officially descriptive of either of the two conditions) are two completely different conditions with totally separate etiologies.

Celiac disease is an autoimmune disease caused by an attack by antibodies on healthy tissue, non-celiac gluten sensitivity, as discovered by eminent researcher Dr. Alessio Fasano, is a problem of the more primitive "innate" immue system. Although symptoms are similar, and triggered by gluten ingestion, NCGS is not considered to be as severe since it isn't accompanied by tissue destruction. NCGS can be extremely disruptive to the individual, however, causing neurological disturbances and digestive problems similar to celiac disease. Note that there are other autoimmune and digestive disorders that cause similar symptoms.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.